MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.vaccine.2025.127608

Медицинская библиотека · Vaccine · 2025

COVID-19 testing acceptance among symptomatic individuals screened for a randomized clinical trial in The Gambia.

Grey-Johnson Mary, Muhammad Abdul Khalie, Sillah Fatoumata, Jones Chiquita Joquina, Sarr Catherine, Babatunde Hakeem Edun, Dibba Bakary, Ndure Ebrahim, Bojang Lamin, Roberts Charles, Bittaye Mustapha, Mohammed Nuredin, Nadjm Behzad, D'Alessandro Umberto, Roca Anna, Usuf Effua

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Testing is a critical component to control disease outbreaks. The screening process required to enrol study participants from individuals with suspected COVID-19 disease in a clinical trial, presented an opportunity to explore factors that influence the willingness to be tested for COVID-19.

METHODS

We analyzed data from individuals with symptoms suggestive of mild-moderate COVID-19 in two different health facilities in Western Gambia. As part of pre-enrollment screening for recruitment into a COVID-19 drug trial, we recorded clinical, epidemiological, and demographic information. Individuals who consented had a nasopharyngeal and/or oropharyngeal sample collected for SARS-CoV-2 testing. We compared consenting and non-consenting individuals using univariate and multivariable logistic regression and calculated adjusted odds ratio. Over-time trends were visualised using a 30-day moving sum for participants who consented.

RESULTS

Among the 1361 suspected COVID-19 individuals identified between January 2021 and August 2022, 33.4 % (458/1361) consented to be tested for SARS-CoV-2. In the multivariate analysis, history of smoking (aOR: 3.07, 95 %CI: 1.60-5.88 p < 0.001), high educational level (aOR: 6.32, 95 %CI: 3.84-10.39 p < 0.001), history of travel (aOR: 2.94, 95 %CI: 1.20-7.22, p = 0.019), and loss of smell (aOR: 4.00, 95 %CI: 2.24-7.17 p = 0.002,) were significantly associated with acceptance to COVID-19 testing. The 30-day moving sum showed a downward trend of testing acceptance over time.

CONCLUSION

Although testing acceptance was very low, individuals with recognised risk factors for COVID-19 were more likely to accept testing. Early and sustained information about these risk factors particularly targeting individuals in low-education cadres may enhance testing uptake during a pandemic.

Для цитирования: Grey-Johnson Mary, Muhammad Abdul Khalie, Sillah Fatoumata, Jones Chiquita Joquina, Sarr Catherine, Babatunde Hakeem Edun, Dibba Bakary, Ndure Ebrahim, Bojang Lamin, Roberts Charles, Bittaye Mustapha, Mohammed Nuredin, Nadjm Behzad, D'Alessandro Umberto, Roca Anna, Usuf Effua. COVID-19 testing acceptance among symptomatic individuals screened for a randomized clinical trial in The Gambia.. Vaccine. 2025. DOI: 10.1016/j.vaccine.2025.127608.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.